Health Trials

Primary Peritoneal Cavity Cancer

2

Review clinical trials related to Primary Peritoneal Cavity Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

A Study of Emi-Le in Participants with Solid Tumors

Participants needed: 360
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Day One Biopharmaceuticals, Inc.Updated: Jun 29, 2026Locations: 26
Eligibility criteria

Recurrent or advanced solid tumor and has disease [+5]

Prior treatment with an Antibody Drug Conjugate (ADC) containing an auristatin p... [+8]

Read more
Status: Recruiting

Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

This is a phase 2 study to test the effectiveness (anti-tumor activity) of the combination of the study drugs, Senaparib and Temozolomide, in patients with clear cell or endometrioid ovarian cancers that have ARID1A pathologic variants.

Participants needed: 18
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsUpdated: Oct 27, 2025Locations: 2
Eligibility criteria

Ability to understand and the willingness to sign a written informed consent doc... [+27]

Prior treatment with a poly ADP ribose polymerase (PARP) inhibitor or temozolomi... [+19]

Read more